16,208 Shares in SPDR S&P China ETF $GXC Bought by Bleakley Financial Group LLC

Bleakley Financial Group LLC acquired a new stake in SPDR S&P China ETF (NYSEARCA:GXC) during the first quarter, HoldingsChannel reports. The fund acquired 16,208 shares of the company’s stock, valued at approximately $1,509,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Jones Financial Companies Lllp raised its position in SPDR S&P China ETF by 4,448.1% during the 1st quarter. Jones Financial Companies Lllp now owns 3,593 shares of the company’s stock worth $309,000 after buying an additional 3,514 shares during the last quarter. JPMorgan Chase & Co. boosted its holdings in shares of SPDR S&P China ETF by 14.4% in the second quarter. JPMorgan Chase & Co. now owns 4,545 shares of the company’s stock valued at $398,000 after acquiring an additional 573 shares in the last quarter. First Trust Advisors LP boosted its holdings in shares of SPDR S&P China ETF by 11.0% in the second quarter. First Trust Advisors LP now owns 6,170 shares of the company’s stock valued at $540,000 after acquiring an additional 613 shares in the last quarter. Qube Research & Technologies Ltd increased its stake in shares of SPDR S&P China ETF by 136.1% during the second quarter. Qube Research & Technologies Ltd now owns 491 shares of the company’s stock worth $43,000 after acquiring an additional 283 shares during the period. Finally, Raymond James Financial Inc. acquired a new position in shares of SPDR S&P China ETF during the second quarter worth about $122,000.

SPDR S&P China ETF Stock Down 0.5%

NYSEARCA GXC opened at $89.59 on Friday. The stock has a market capitalization of $452.43 million, a P/E ratio of 12.97 and a beta of 0.35. SPDR S&P China ETF has a 52-week low of $85.03 and a 52-week high of $107.01. The firm has a 50-day moving average price of $91.20 and a 200 day moving average price of $95.50.

About SPDR S&P China ETF

SPDR S&P China ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P/Citigroup BMI China Index (the Index). The Index is a market capitalization-weighted index that defines and measures the investable universe of publicly traded companies domiciled in China, but legally available to foreign investors. The Index is float adjusted, meaning that only those shares publicly available to investors are included in the Index calculation. The Fund uses a passive management strategy designed to track the price and yield performance of the Index.